Sutro Biopharma Inc. logo

Sutro Biopharma Inc.

STRO | NASDAQ
Chart Builder DCF Calculator
$16.35
+$1.01 (+6.58%)
At close: Sep 21, 2026, 4:00 PM ET
$16.35
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$158.22M
Enterprise Value
$4.66M
Beta
1.49
Average Volume
323.31K
Shares Outstanding (Diluted)
16.57M
Shares Change YoY
95.93%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US8693672011

Price Performance

Price Change 1M
-23.2%
Price Change 3M
-44.0%
Price Change 6M
-30.4%
Price Change YTD
49.2%
Price Change 1Y
83.7%
Price Change 3Y
-50.5%
Price Change 5Y
-91.5%
1M CAGR (ann.)
-35.6%
1Y CAGR (ann.)
81.1%
5Y CAGR (ann.)
-39.4%
All-Time CAGR
-24.4%

Valuation

PE Ratio
-0.94
Forward PE
N/A
PEG Ratio
-0.03
Forward PEG
0.05
PS Ratio
3.46
Forward PS
4.60
PB Ratio
-1.53
P/FCF Ratio
-1.09
P/Adj. FCF Ratio
-1.04
P/OCF Ratio
-1.87
EV/Sales
0.10
EV/EBIT
-0.03
EV/EBITDA
-0.03
EV/FCF
-0.03
Earnings Yield
-106.5%
FCF Yield
-92.0%
Adj. FCF Yield
-96.3%

Financial Health

Net Cash
$164.35M
Total Debt
$10.78M
Cash & Short-Term Investments
$164.35M
Total Assets
$194.46M
Current Ratio
3.32
Quick Ratio
3.32
Debt / Equity Ratio
-0.10
Debt / EBITDA
-0.08
Debt / FCF
-0.07
OCF / Debt
-13.46
Interest Coverage
-3.53
Altman Z-Score
-8.67
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
97.2%
Operating Profit Margin
-309.9%
EBITDA Margin
-294.5%
Net Profit Margin
-395.3%
FCF Margin
-318.6%
Adj. FCF Margin
-333.5%
SBC / Revenue
14.8%
SBC Impact (per share)
-4.7%

Returns

Return on Assets
-92.9%
Return on Equity
185.3%
Return on Invested Capital
-95.5%
Return on Capital Employed
-100.0%
Return on Tangible Assets
-92.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
-7.0%
Revenue CAGR 5Y
-7.9%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
2.4%
EPS CAGR 5Y
9.8%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-21.4%
FCF CAGR 5Y
-23.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
20
EPS Growth Next 3Y
22.5%
Revenue Growth Next 3Y
-5.8%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$1.66
EPS Growth Est (next Q)
-75.2%
Revenue Est (next Q)
$13.61M
Revenue Growth Est (next Q)
40.4%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$51
Price Target Upside
211.9%

Cash Flow

Operating Cash Flow
$-145.17M
Free Cash Flow
$-145.62M
Adj. Free Cash Flow
$-152.4M
FCF Per Share
-$8.79
OCF Per Share
-$8.76
OCF/S Ratio
-317.7%

Income Statement

Revenue
$45.7M
Gross Profit
$44.42M
Operating Income
$-141.62M
EBITDA
$-134.6M
Net Income
$-180.64M
EPS (Diluted)
-$17.42
Revenue / Employee
$357.05K
Profit / Employee
$-1.41M
Employees
128

© 2026 bestshares.com. All rights reserved.